Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Biquelle XL 50mg tablets
0402010ABBIAAAV
|
Biquelle XL | Quetiapine | Central Nervous System | 9,468 |
|
Biquelle XL 300mg tablets
0402010ABBIADAX
|
Biquelle XL | Quetiapine | Central Nervous System | 8,674 |
|
Biquelle XL 200mg tablets
0402010ABBIACAW
|
Biquelle XL | Quetiapine | Central Nervous System | 7,034 |
|
Biquelle XL 400mg tablets
0402010ABBIAEAY
|
Biquelle XL | Quetiapine | Central Nervous System | 6,653 |
|
Biquelle XL 150mg tablets
0402010ABBIABBA
|
Biquelle XL | Quetiapine | Central Nervous System | 4,081 |
|
Biquelle XL 600mg tablets
0402010ABBIAFBG
|
Biquelle XL | Quetiapine | Central Nervous System | 468 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.